Press Releases

Press Releases

Morphic Announces Participation in Upcoming Investor Conferences

September 3, 2020
WALTHAM, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced participation in the following investor conferences: Praveen
Displaying 1 - 10 of 19